Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
Public ClinicalTrials.gov record NCT07473778. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pioneering Research to Optimize Pre-exposure Prophylaxis (PrEP) Expansion With Lenacapavir (LEN)
Study identification
- NCT ID
- NCT07473778
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Gilead Sciences
- Industry
- Enrollment
- 3,000 participants
Conditions and interventions
Conditions
Interventions
- Cabotegravir (CAB) Drug
- Emtricitabine/tenofovir alafenamide (F/TAF) Drug
- Emtricitabine/tenofovir disoproxil fumarate (F/TDF) Drug
- Lenacapavir Injection Drug
- Lenacapavir Tablet Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 16, 2026
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2029
- Last update posted
- Apr 2, 2026
2026 – 2029
United States locations
- U.S. sites
- 4
- U.S. states
- 4
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bliss Health | Orlando | Florida | 32803 | Recruiting |
| Faebris Medical & Community Education | Atlanta | Georgia | 01111 | Recruiting |
| Be Well Medical Center | Berkley | Michigan | 48072 | Recruiting |
| KC Care Health Center | Kansas City | Missouri | 64111 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07473778, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 2, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07473778 live on ClinicalTrials.gov.